Grace Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Grace Therapeutics Inc
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
/ 
Others were interested in
Frequently asked questions
To buy Grace Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Grace Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Grace Therapeutics Inc is GRCE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Grace Therapeutics Inc has its primary listing on NASDAQ (Small cap). You can trade Grace Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Grace Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Grace Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Grace Therapeutics Inc.